Its regulatory status has not halted demand either
If a patient gets good weight loss results from Zepbound, switching to Wegovy is unlikely to improve results
However, they may contain ingredients that, when used excessively, can cause diarrhea and electrolyte imbalances, contributing to conditions like bleeding
However, Lemon Bottle still lacks large-scale clinical trials and regulatory approval, meaning patients should approach it with cautious optimism
The FDA maintains a list of substances allowed to be compounded by outsourcing facilities as part of the 503B drug program, and its looking to exclude semaglutide, tirzepatide and liraglutidepopular weight loss drugsas part of a crackdown on the online availability of these drugs, all part of the larger GLP-1 market